NCT01506154

Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder

A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Topical Patch in the Treatment of Pain Due to Recent Onset Supraspinatous and/or Subacromial Tendonitis/Bursitis and/or Subdeltoid Bursitis of Shoulder

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 210 (actual)
• Sponsor: MEDRx USA, Inc. · Industry
• Sex: All
• Age: 14 Years
• Healthy volunteers: Not accepted

Summary

A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Pain due to Recent Onset Supraspinatous and/or Subacromial Tendonitis/Bursitis and/or Subdeltoid Bursitis of the Shoulder.

Conditions

• Bursitis
• Tendonitis
• Shoulder Pain

Interventions

Type	Name	Description
DRUG	MRX-7EAT	Once daily application of a patch for 14 days

Timeline

• Start date: 2011-12-01
• Primary completion: 2012-10-01
• Completion: 2012-10-01
• First posted: 2012-01-09
• Last updated: 2018-01-16

Locations

27 sites across 1 country: United States